About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Clinical Trials in Tennessee | 18,976 Studies Near You

Clinical TrialsTennessee

Clinical Trials in Tennessee

Discover 18,976 clinical trials near Tennessee. Find research studies in your area.

Browse by condition:

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia Lymphoma Pancreatic Cancer

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 4921-4940 of 18,976 trials

CompletedA Study to Examine the Safety, Tolerability and Effects on Abnormal Bone Formation of REGN2477 in Patients With Fibrodysplasia Ossificans ProgressivaThis is a three period study design consisting of a 6-month, randomized, double-blind placebo-controlled treatment (period 1) followed by a 6-month, open-label treatment (period…NCT03188666·Rochester, Minnesota and 10 others

Find Trials by Condition in Tennessee

Breast Cancerin Tennessee Lung Cancerin Tennessee Prostate Cancerin Tennessee Colorectal Cancerin Tennessee Melanomain Tennessee Leukemiain Tennessee Lymphomain Tennessee Pancreatic Cancerin Tennessee Ovarian Cancerin Tennessee Brain Cancerin Tennessee

Data from ClinicalTrials.govTerms

TerminatedA Study to Evaluate the Long-term Safety and Tolerability of SAGE-324 in Participants With Essential TremorThe primary purpose of this study is to evaluate the long-term safety and tolerability of SAGE-324 in participants with essential tremor (ET).NCT05366751·Hoover, Alabama and 37 others

Enrolling by invitationAssessment of Esophageal Epithelium Integrity With Use of a Novel Mucosal Impedance DeviceThe objective of this study is to design and use a novel, minimally invasive mucosal impedance (MI) technology to inexpensively and accurately test mucosal health in suspected…NCT03103789·Nashville, Tennessee

CompletedRadiation Therapy Plus Paclitaxel in Treating Patients With Nonmetastatic, Unresectable Pancreatic CancerRATIONALE: Radiation therapy uses high-energy x-rays to damage tumor cells.NCT00003591·Birmingham, Alabama and 233 others

CompletedCryopreserved Human Umbilical Cord (TTAX01) for Late Stage, Complex Non-healing Diabetic Foot Ulcers (AMBULATE DFU)It is hypothesized that application at 4-week or greater intervals of the human placental umbilical cord tissue TTAX01 to the surface of a well debrided, complex diabetic foot…NCT04176120·San Francisco, California and 15 others

RecruitingEvaluation Of Cardiovascular Health Outcomes Among Survivors 2Childhood cancer survivors who received certain treatments are at a higher risk of developing heart problems in the future.NCT07245420·Memphis, Tennessee

CompletedEffect of Liraglutide for Weight Management in Pubertal Adolescent Subjects With ObesityThis trial is conducted globally. The aim of this trial is to investigate the effect of liraglutide for weight management in pubertal adolescent subjects with obesity.NCT02918279·Meridian, Idaho and 32 others

CompletedEvaluating The Antitumor Activity Of MEDI-522 With Or Without Dacarbazine In Patients With Metastatic MelanomaThe primary objectives of this study are: * To explore the antitumor activity of MEDI-522 ± DTIC in patients with metastatic melanoma.NCT00066196·Scottsdale, Arizona and 24 others

CompletedEight-Week Efficacy & Safety Study of Brisdelle™ (Formerly Known as Mesafem) in the Treatment of Vasomotor Symptoms Associated With MenopauseThis is an exploratory 8-week, multicenter, double-blind, randomized, placebo-controlled study of Brisdelle (paroxetine mesylate) Capsules 7.5 mgin subjects with moderate to…NCT00786188·Lake Worth, Florida and 9 others

CompletedAn Open-Label Study to Evaluate the Safety of NP101 in the Treatment of Acute Migraine Over 12 MonthsThe primary objective is to evaluate the safety of long-term treatment with NP101 as assessed by: * Subject self-examination skin irritation scores * Adverse events * Changes in…NCT00792103·Phoenix, Arizona and 33 others

CompletedRadiation Therapy in Treating Patients With Stage II Cancer of the Vocal CordRATIONALE: Radiation therapy uses high-energy x-rays to damage tumor cells.NCT00002727·Birmingham, Alabama and 236 others

CompletedChemotherapy and Radiation Therapy in Treating Young Patients With Newly Diagnosed, Previously Untreated, High-Risk Medulloblastoma/PNETThis phase III trial studies different chemotherapy and radiation therapy regimens to compare how well they work in treating young patients with newly diagnosed, previously…NCT00392327·Birmingham, Alabama and 184 others

RecruitingBereaved Parent Conversations on HopeThis study looks at whether it is possible and helpful to have video call conversations about how hopes can change through the cancer journey between bereaved parents and learners…NCT07675083·Memphis, Tennessee

TerminatedStudy to Assess the Efficacy and Safety of Ublituximab + Umbralisib With or Without Bendamustine and Umbralisib Alone in Patients With Previously Treated Non-Hodgkins LymphomaUnity NHL - A Phase 2b Randomized Study to Assess the Efficacy and Safety of the Combination of Ublituximab + Umbralisib with or without Bendamustine and Umbralisib alone in…NCT02793583·Birmingham, Alabama and 167 others

RecruitingTesting the Addition of an IDH2 Inhibitor, Enasidenib, to Usual Treatment (Cedazuridine-Decitabine) for Higher-Risk Myelodysplastic Syndrome (MDS) With IDH2 Mutation (A MyeloMATCH Treatment Trial)This phase II MyeloMATCH treatment trial compares the usual treatment of cedazuridine-decitabine (ASTX727) to the combination treatment of ASTX727 and enasidenib in treating…NCT06577441·Berkeley, California and 146 others

Active not recruitingAcalabrutinib for the Treatment of Chronic Graft Versus Host DiseaseThis phase II trial studies how well acalabrutinib works in treating patients with chronic graft versus host disease.NCT04198922·Tampa, Florida and 5 others

CompletedAn Investigational Drug, PF-02341066, Is Being Studied In Patients With Advanced Non-Small Cell Lung Cancer With A Specific Gene Profile Involving The Anaplastic Lymphoma Kinase (ALK) GeneThis is a Phase 2 trial that will evaluate the safety and efficacy of PF-02341066 in patients with advanced non-small cell lung cancer with a specific gene profile involving the…NCT00932451·Birmingham, Alabama and 279 others

TerminatedPilot Study to Enable Electronic Laboratory Data Transfer From Participating Institutions to MediData/RAVEAn initial step toward more accurate and complete data acquisition for clinical trials, the Pediatric Early Phase Clinical Trials Network (PEP-CTN) and Pediatric Brain Tumor…NCT05020951·San Francisco, California and 7 others

Active not recruitingDocetaxel or Paclitaxel in Reducing Chemotherapy-Induced Peripheral Neuropathy in African American Patients With Stage I-III Breast CancerThis phase II trial studies how well docetaxel or paclitaxel work in reducing chemotherapy-induced peripheral neuropathy in African American patients with stages I-III breast…NCT04001829·Birmingham, Alabama and 481 others

Active not recruitingThe Synergy Disc To Anterior Cervical Discectomy and FusionA multicenter, prospective, non-randomized, historically controlled study.NCT04469231·Phoenix, Arizona and 19 others

PreviousPage 247 of 949Next

Diabetes

in Tennessee

Heart Diseasein Tennessee